How we enable you to make an impact
Improve patients’ health status through personalized prescribing informed by MTM, clinical lab data and the latest genomic science. Reduce costs by eliminating ineffective and harmful drugs from therapy regimens.
Trial-and-error and one-size-fits all prescribing result in more than 2 million Adverse Drug Reactions (ADRs) a year.¹ Suboptimal medication use causes 275,000 deaths and wastes $528 billion every year.²
hc1 PrecisionRx Advisor® (hc1 PRx Advisor™) is the only solution that combines Medication Therapy Management (MTM), PharmacoGenomics (PGx), clinical lab data and integrated engagement and monitoring workflows in a single platform. Integrated lab and patient data essential to precision prescribing and uncovering otherwise hidden risks enables an optimal medication plan designed just for the patient, lowering the overall cost of care.
To select the safest and most effective medication plan for the patient from the more than 10,000 prescription medications available, providers need to take into account the patient’s condition, health history, lifestyle and genetics. With data typically siloed in separate systems, some spend precious time hunting for insights while many more rely on a one-size-fits all approach to treating the patient. This inefficient method leads to wasted time, ineffective treatments and high costs for patients and payers.
How can providers access the additional clinical information they need to personalize prescribing without added time or cost?
By organizing and normalizing the patient’s genetics, lifestyle and health profile in the hc1 Precision Health Platform™, PRx Advisor enables providers and pharmacists to collaborate and make precision prescribing decisions with just a click. This unique approach ensures the right patient gets the right prescription based on their own personal profile.
While some precision prescribing decisions can be based on MTM and clinical lab data alone, drugs with genetic implications are not rare: 52% of the 50 most common drugs have genetic implications for efficacy and patient safety.
Using award-winning hc1 PGx Advisor as a component of PRx Advisor, ensures a patient’s unique genetic profile is taken into consideration alongside other clinical lab data, medications, lifestyle and health profiles.
hc1 PGx Advisor was chosen as Tech Product of the Year during TechPoint’s 21st annual Mira Awards, an awards gala to honor “Best of Tech” in Indiana. Accepted by Reed Richardson, Vice President of Rx Business Operations, this award commemorates the success of the hc1 PGx Advisor in improving patient care.
hc1 PGx Advisor was chosen as Tech Product of the Year during TechPoint’s 21st annual Mira Awards, an awards gala to honor “Best of Tech” in Indiana. Accepted by Reed Richardson, Vice President of Rx Business Operations, this award commemorates the success of the hc1 PGx Advisor in improving patient care.